Print Page   |   Contact Us
About
Share |

Mission


The Massachusetts Prostate Cancer Coalition (MPCC) educates, connects, and supports men-at-risk, newly diagnosed individuals, survivors, and their families. It also connects organizations and professionals in Massachusetts that seek to conquer and cure prostate cancer.

 

About Prostate Cancer


  • It is the most commonly diagnosed type of cancer for men in Massachusetts.
  • 1 in 7 men will be diagnosed with prostate cancer during their lifetime.
  • Prostate cancer is the most common (non-skin) cancer in American men, representing 33% of all new cases.
  • In Boston, prostate cancer has emerged as the most lethal malignancy in African American men. (Boston Public Health Commission)
  • Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer.
  • It is estimated that in 2019, there will be 174,650 new cases of prostate cancer diagnosed and that close to 31,620 men will die of the disease. Yet, most men diagnosed with prostate cancer will not die from it. In fact, more than 2.9 million men in the United States who have been diagnosed with prostate cancer are still alive today.
  •  

    About MPCC


  • MPCC is a nonprofit organization 501(c)(3) public charity founded in 2001.
  • MPCC has more than 2000 members and friends of the organization.
  • MPCC’s board is made up of survivors, medical professionals, representatives of related organizations, and others interested in prostate cancer research, diagnosis, and treatment.
  • MPCC is guided, in part, by a distinguished Medical Advisory Committee with representatives from leading hospitals and health care providers in the Commonwealth.
  • MPCC is a participant in the National Alliance of State Prostate Cancer Coalitions (NASPPC).
  •  

    Board of Directors


    Allen L. Snyder III, chairman  Northwestern Mutual
    Garth Greimann, secretary & treasurer
    Lynn A. Basilio,  American Cancer Society
    John Carberry, Charles River Mortgage Company, Inc.
    Les Cavicchi, Greater Boston Urology, LLC
    Jason A. Efstathiou, MD, DPhil, Massachusetts General Hospital
    David S. Godkin, Birnbaum & Godkin, LLP
    Mark Anthony Hunter, The Goddard School
    Robert Kretschmar, Global Capital Resources, Inc.
    Tiffany Nagle, Cullari Communications Global
    C. Kirk Neison
    Avi Nelson
    Dalton A. Skerritt, CEHSID

     

    Directors Emeriti


    Arnold Barron
    Thomas L. Farmer
    Neal F. Finnegan
    Robert S. Lyons

     

    Medical Advisory Committee


    Richard K. Babayan, MD, Boston Medical Center
    Glenn J. Bubley, MD, Beth Israel Deaconess Medical Center
    J. Jacques Carter, MD, MPH, Beth Israel Deaconess Medical Center
    Jason R. Gee, MD, Emerson Urology Associates
    Adam Kibel, MD, Brigham and Women’s Hospital
    Richard Jaebong Lee, MD, Massachusetts General Hospital 
    Paul Nguyen, MD, Brigham and Women’s Hospital
    William U. Shipley, MD, Massachusetts General Hospital
    Mary-Ellen Taplin, MD, Dana-Farber Cancer Institute
    Ingolf A. Tuerk, MD, PhD, Caritas St. Elizabeth’s Medical Center

     

    Symposium Planning Committee


    Anita Christie, Massachusetts Department of Public Health
    Judy Green, Massachusetts Prostate Cancer Coalition
    Mark Kennedy, Boston Public Health Commission
    Tiffany Nagle, Cullari Communications Global
    Joanne Pokaski, Beth Israel Deaconess Medical Center
    Dalton A. Skerritt, CEHSID
    Allen L. Snyder III, Northwestern Mutual
    William Tinney, Support Group Leader

     

    BOTTOM
    Association Management Software Powered by YourMembership  ::  Legal